Clinical Refractometers in Canada vs the US: Which Class Applies?

Stacks of birch wood tongue depressors banded in paper beside a loose pile

Quick facts

  • A refractometer for clinical use determines the amount of solute in a solution by measuring the index of refraction, which is used for analytes such as plasma total proteins and urinary total solids.
  • In the United States it is a named entry. 21 CFR 862.2800 is Class I, with product codes JRE (for clinical use) and PSM (for donor testing).
  • Canada keeps no named entry. An instrument intended for use in diagnosis is an in vitro diagnostic device, and Part 2, Rule 4 of Schedule 1 places it in Class II.
  • Two product codes under one US section are worth noticing: the donor-testing refractometer serves a different decision than the clinical one, although both are Class I.
  • Part 2 Rule 7 applies where the refractometer is used with another IVDD: the class of both is the higher class.
  • Entries, classes and product codes below were checked against the eCFR, the Regulations and the openFDA classification database on 2026-10-15.

A refractometer for clinical use measures the index of refraction of a solution and turns that reading into a solute concentration — plasma total proteins and urinary total solids are the two examples the regulation itself gives. The United States keeps the instrument at Class I; Canada treats it as an in vitro diagnostic device and reaches Class II. This article sets out both routes and the bench record that goes with a refractometric method, with the 120 mL screw-cap specimen containers used to carry the sample to the bench.

What is a clinical refractometer?

A refractometer measures the ratio of the velocity of light in a vacuum to the velocity of light in the solution — the index of refraction — and reports the result as a concentration. The identification at 21 CFR 862.2800 states the purpose and the examples: the device is "intended to determine the amount of solute in a solution by measuring the index of refraction", and the measurement "is used to measure the concentration of certain analytes (solutes), such a plasma total proteins and urinary total solids".

Two practical properties follow. First, the reading depends on temperature, because the index of refraction of a liquid does. Second, the instrument is usually read by eye through an eyepiece, which makes the operator's technique part of the measurement. Both facts belong in the record, not only in the training folder.

Stacks of birch wood tongue depressors banded in paper beside a loose pile

What class is a clinical refractometer in the United States?

It is a named entry at Class I (general controls), exempt from premarket notification under subpart E of part 807 subject to the limitations in section 862.9. The openFDA device classification API returns two product codes for the section: JRE for the refractometer for clinical use and PSM for the refractometer for donor testing.

The split is useful when a laboratory is comparing instruments. The clinical refractometer supports a diagnostic or management decision about a patient; the donor-testing instrument supports a decision about a donation. Both are Class I in the United States, and both are in the diagnostic chain in Canada.

Item Detail
US regulation 21 CFR 862.2800 - Refractometer for clinical use
US class Class I (general controls)
Product codes JRE (refractometer for clinical use), PSM (refractometer for donor testing)
Stated intended use Determine the amount of solute in a solution by measuring the index of refraction
Examples stated in the entry Plasma total proteins and urinary total solids
Premarket route Exempt from premarket notification under subpart E of part 807, subject to section 862.9

How does Canada classify a clinical refractometer?

Canada keeps no named entry. The instrument examines specimens taken from the human body and its readings are used in diagnosis, which makes it an in vitro diagnostic device under Schedule 1, Part 2. Rule 4 is the governing text: "An IVDD that is not subject to rules 1 to 3 and that is intended to be used in diagnosis or patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III."

The classes escalate inside that rule. Where the same instrument is used in cancer screening or diagnosis, in genetic testing, in fetal congenital-disorder screening, in disease staging, or to monitor drug or substance levels where an erroneous result could lead to an imminent life-threatening decision, the class becomes Class III. The instrument does not change; the use does.

Rule 7 carries the same logic further: "In cases where an IVDD, including its analyzers, reagents and software, is intended to be used with another IVDD, the class of both IVDDs will be that of the IVDD in the class representing the higher risk." And Rule 8 gives the residual: if rules 1 to 7 do not apply, the IVDD is Class I. For a refractometer the practical reading is that the routine clinical use reaches Class II, and any tie to a higher-class assay pulls the class up with it.

Item Canada United States
Named entry None; classified by rule 862.2800 - Refractometer for clinical use
Class Class II (Part 2 Rule 4, diagnosis or patient management) Class I
Class III route Rule 4 categories, or Rule 7 where used with a higher-class IVDD Not provided for in the entry
Governing text Schedule 1, Part 2, Rules 4, 7 and 8 21 CFR 862.2800
Product codes No Canadian product-code system JRE, PSM
Licence route Device licence (Class II) with quality-system evidence Exempt from premarket notification, subject to section 862.9
Graduated plastic specimen container with a screw cap on a dark background

Why does the United States keep it at Class I?

Because the entry classifies a measuring instrument, and the United States puts the clinical claim where it belongs — with the method and the reagent system the laboratory uses. A refractometer reported a number long before it was reported into a diagnostic pathway, and the entry reflects that: the device is a reader, and the reading is judged by the laboratory.

Canada classifies the same instrument by what it is used for. Once the maker states that the readings are used in diagnosis or patient management, the device is in the in vitro diagnostic chain and Rule 4 applies. The two answers are not in conflict; they answer different questions about the same box on the bench.

What should a laboratory check before buying one?

Four checks. First, confirm which product code the instrument is sold under, because the clinical and donor-testing versions serve different decisions even though both are Class I in the United States. Second, confirm the temperature compensation the maker states, since the index of refraction moves with temperature and an uncompensated instrument needs a controlled bench. Third, confirm the calibration and verification materials the maker supplies, and how often the maker says they should be used. Fourth, confirm the stated intended use in the labelling, because that is what decides the Canadian class.

Laboratories that order for several benches reorder the sample containers used to move specimens to the bench. Clinics that stock for a whole practice can order through the wholesale programme and request a bulk quote for a standing or annual order; the 120 mL screw-cap specimen containers sits in the same catalogue. Consumables for this line are listed under diagnostic laboratories. Reselling? become a distributor.

How does the class affect the bench record?

It does not. The class sets the licence the supplier holds and the review the instrument received before it reached the bench. The record is set by the laboratory quality system and by the maker's instructions: sample identifier, temperature, calibration status, the reading, and the operator, with the reference interval the laboratory has adopted.

That record is what makes a refractometric result usable later. A number without the temperature and the calibration status beside it cannot be compared with a number taken next month, and comparison is the whole point of a longitudinal laboratory record.

Sources

  1. openFDA device classification API
  2. Medical Devices Regulations, SOR/98-282, full text and Schedule 1
  3. US FDA, medical device databases
  4. US FDA, overview of device regulation
  5. Health Canada, medical devices
  6. Health Canada, establishment licensing
  7. ISO 15189:2022, medical laboratories, requirements for quality and competence
  8. ISO 17511:2020, metrological traceability of values assigned to calibrators
  9. ISO 13485:2016, medical devices quality management
  10. ISO 14971:2019, application of risk management to medical devices
  11. ISO 20776-1:2019, susceptibility testing of infectious agents
  12. Clinical and Laboratory Standards Institute
  13. World Health Organization
  14. US CDC, laboratory quality
  15. Public Health Ontario, infection prevention and control
  16. Standards Council of Canada
  17. CCOHS, OSH answers

A printable bench calibration sheet. The fields a refractometer log needs — date, instrument, temperature, calibration material, reading and operator — fit on one page. Open the compliance log centre and print the blank sheet: no account and no sign-up, and it can be copied for every bench.

One dated set for the month. Enter the laboratory name, the instrument and the calibration interval once, and the sterilization log generator lays out dated rows you can print or file with the bench records.

Ask a compliance specialist. A classification question usually turns on how the device is used, not only on its name. Ask a compliance specialist — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.

Related reading

CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.

Frequently Asked Questions

What class is a clinical refractometer in the United States?

Class I. It is a named entry at 21 CFR 862.2800 with product code JRE, or PSM where it is sold for donor testing.

What class is it in Canada?

Class II. It is an in vitro diagnostic device intended for use in diagnosis or patient management, which Part 2 Rule 4 of Schedule 1 classifies as Class II.

What analytes does the regulation name?

The identification names plasma total proteins and urinary total solids as examples of the concentration measurements the device supports.

When would a refractometer be Class III in Canada?

Where the use falls into a Rule 4 category — cancer screening or diagnosis, genetic testing, fetal screening, disease staging, or drug-level monitoring with an imminent life-threatening consequence — or where Part 2 Rule 7 makes it share the class of a higher-risk IVDD it is used with.

Why is temperature part of the record?

Because the index of refraction of a liquid changes with temperature, so the reading is only comparable with an earlier one when the temperature or the compensation is known.

Does the class change the consumables a laboratory stocks?

No. The class sets the market-entry path. The consumables follow the sample volume and the bench workflow: containers for transport and cups for the reading.

Vous travaillez déjà avec des cliniques ? Devenez représentant régional.